Discontinued — last reported Q3 '23
Business Segments · Operating profit
Proprietary Products — Operating profit
West Pharmaceutical Services Proprietary Products — Operating profit decreased by 6.5% to $181.60M in Q3 2023 compared to the prior quarter. Year-over-year, this metric declined by 3.7%, from $188.60M to $181.60M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2023
Rolls up toOperating Income
How to read this metric
Higher profit indicates strong operational efficiency and pricing power within the segment.
Detailed definition
Operating profit for the Proprietary Products segment measures the profitability of the core business operations after d...
Peer comparison
Standard 'Segment Operating Income' reported by most diversified manufacturing and life sciences companies.
Metric ID:
wst_segment_proprietary_products_operating_profitHistorical Data
6 periods
| Q2 '21 | Q3 '21 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | |
|---|---|---|---|---|---|---|
| Value | $216.20M | $195.50M | $233.90M | $188.60M | $194.20M | $181.60M |
| QoQ Change | — | -9.6% | +19.6% | -19.4% | +3.0% | -6.5% |
| YoY Change | — | — | +8.2% | -3.5% | -17.0% | -3.7% |
Range$181.60M – $233.90M
CAGR-13.0%
Avg YoY Growth-4.0%
Median YoY Growth-3.6%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's proprietary products — operating profit?
- West Pharmaceutical Services (WST) reported proprietary products — operating profit of $181.60M in Q3 2023.
- How has West Pharmaceutical Services's proprietary products — operating profit changed year-over-year?
- West Pharmaceutical Services's proprietary products — operating profit decreased by 3.7% year-over-year, from $188.60M to $181.60M.
- What does proprietary products — operating profit mean?
- The profit generated by the segment's core business activities before interest and taxes.